对澳大利亚医院环境中智障成年患者的《用药安全标准》应用进行合理调整

IF 1 Q4 PHARMACOLOGY & PHARMACY Journal of Pharmacy Practice and Research Pub Date : 2024-03-19 DOI:10.1002/jppr.1889
Robyn Anne Wallace BSc(Hons), DipEd, MSc, MBBS, FRACP, CF, PhD, FAFRM, GDipNeurosci, ClinDipPallCare, MDisPrac, GChPom, GCertHealthMment
{"title":"对澳大利亚医院环境中智障成年患者的《用药安全标准》应用进行合理调整","authors":"Robyn Anne Wallace BSc(Hons), DipEd, MSc, MBBS, FRACP, CF, PhD, FAFRM, GDipNeurosci, ClinDipPallCare, MDisPrac, GChPom, GCertHealthMment","doi":"10.1002/jppr.1889","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Purpose of review</h3>\n \n <p>Adults living with intellectual disability experience higher rates of preventable adverse medication events across the medicine pathway compared to their peers without disability.</p>\n </section>\n \n <section>\n \n <h3> Source of information</h3>\n \n <p>The Medication Safety Standard, developed by the Australian Commission on Safety and Quality in Health Care, describes systems and strategies to ensure that clinicians and health organisations safely prescribe, dispense, administer appropriate medications to informed patients, and monitor their use.</p>\n </section>\n \n <section>\n \n <h3> Key findings</h3>\n \n <p>Optimal application of the Medication Safety Standard for this population requires the development of reasonable adjustments to its action which take into account the barriers to safe medication management experienced by them in hospital settings. Design of such reasonable adjustments is influenced by consideration of the experiences of medicine management within with people living with intellectual disability, with intellectual disability, the roles of disability supports, and the disability-health sector interface in relation to medication management.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This review describes the formulation of a range of practice point reasonable adjustments to the usual clinical processes, content, knowledge, and organisation required in application of the Medication Safety Standard for adult patients living with intellectual disability.</p>\n </section>\n </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1889","citationCount":"0","resultStr":"{\"title\":\"Reasonable adjustments to application of the Medication Safety Standard for adult patients living with intellectual disability in Australian hospital settings\",\"authors\":\"Robyn Anne Wallace BSc(Hons), DipEd, MSc, MBBS, FRACP, CF, PhD, FAFRM, GDipNeurosci, ClinDipPallCare, MDisPrac, GChPom, GCertHealthMment\",\"doi\":\"10.1002/jppr.1889\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Purpose of review</h3>\\n \\n <p>Adults living with intellectual disability experience higher rates of preventable adverse medication events across the medicine pathway compared to their peers without disability.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Source of information</h3>\\n \\n <p>The Medication Safety Standard, developed by the Australian Commission on Safety and Quality in Health Care, describes systems and strategies to ensure that clinicians and health organisations safely prescribe, dispense, administer appropriate medications to informed patients, and monitor their use.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Key findings</h3>\\n \\n <p>Optimal application of the Medication Safety Standard for this population requires the development of reasonable adjustments to its action which take into account the barriers to safe medication management experienced by them in hospital settings. Design of such reasonable adjustments is influenced by consideration of the experiences of medicine management within with people living with intellectual disability, with intellectual disability, the roles of disability supports, and the disability-health sector interface in relation to medication management.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>This review describes the formulation of a range of practice point reasonable adjustments to the usual clinical processes, content, knowledge, and organisation required in application of the Medication Safety Standard for adult patients living with intellectual disability.</p>\\n </section>\\n </div>\",\"PeriodicalId\":16795,\"journal\":{\"name\":\"Journal of Pharmacy Practice and Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1889\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy Practice and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1889\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1889","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

由澳大利亚医疗保健安全与质量委员会制定的《用药安全标准》描述了确保临床医生和医疗机构安全地为知情患者开具、分配和管理适当药物,并监控药物使用情况的系统和策略。要对这一人群最有效地应用《用药安全标准》,就必须对其行动进行合理调整,以考虑到他们在医院环境中安全用药管理所遇到的障碍。考虑到智障人士、智障者在用药管理方面的经验、残疾人支持机构的作用以及残疾人与卫生部门在用药管理方面的联系,这些合理调整措施的设计都会受到影响。本综述介绍了针对智障成人患者应用《用药安全标准》所需的常规临床流程、内容、知识和组织,制定一系列实践点合理调整措施的情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Reasonable adjustments to application of the Medication Safety Standard for adult patients living with intellectual disability in Australian hospital settings

Purpose of review

Adults living with intellectual disability experience higher rates of preventable adverse medication events across the medicine pathway compared to their peers without disability.

Source of information

The Medication Safety Standard, developed by the Australian Commission on Safety and Quality in Health Care, describes systems and strategies to ensure that clinicians and health organisations safely prescribe, dispense, administer appropriate medications to informed patients, and monitor their use.

Key findings

Optimal application of the Medication Safety Standard for this population requires the development of reasonable adjustments to its action which take into account the barriers to safe medication management experienced by them in hospital settings. Design of such reasonable adjustments is influenced by consideration of the experiences of medicine management within with people living with intellectual disability, with intellectual disability, the roles of disability supports, and the disability-health sector interface in relation to medication management.

Conclusion

This review describes the formulation of a range of practice point reasonable adjustments to the usual clinical processes, content, knowledge, and organisation required in application of the Medication Safety Standard for adult patients living with intellectual disability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmacy Practice and Research
Journal of Pharmacy Practice and Research Health Professions-Pharmacy
CiteScore
1.60
自引率
9.50%
发文量
68
期刊介绍: The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.
期刊最新文献
Issue Information Person- and carer-centred palliative care: consensus for the pharmacy profession Standard of practice in women's and newborn health for pharmacy services Stability of flucytosine 100 mg/mL suspension as an alternative to intravenous administration Rise in paracetamol therapeutic errors in the community during the COVID‐19 pandemic
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1